We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

90 hedge funds and large institutions have $1.16B invested in Theravance Biopharma in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

596% more call options, than puts

Call options by funds: $2.66M | Put options by funds: $383K

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

27% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 26

7% more funds holding

Funds holding: 84 → 90 (+6)

0.31% more ownership

Funds ownership: 86.74% → 87.05% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less capital invested

Capital invested by funds: $1.31B → $1.16B (-$152M)

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
33
Reduced
26
Closed
7
Calls
$2.66M
Puts
$383K
Net Calls
+$2.28M
Net Calls Change
+$3.22M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$11M
2
LCM
Laurion Capital Management
New York
+$7.72M
3
Goldman Sachs
Goldman Sachs
New York
+$7.49M
4
WIM
Woodford Investment Management
United Kingdom
+$4.17M
5
Jane Street
Jane Street
New York
+$3.88M

Top Sellers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
-$22.4M
2
BlackRock
BlackRock
New York
-$4.42M
3
Norges Bank
Norges Bank
Norway
-$1.57M
4
FAM
Foundation Asset Management
New York
-$906K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$846K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$2.94M +$3.33M +121,400 New
OWIM
27
Old West Investment Management
California
$2.65M -$125K -4,542 -4%
Deutsche Bank
28
Deutsche Bank
Germany
$2.65M +$15K +545 +0.5%
TA
29
Teachers Advisors
New York
$2.56M +$77.4K +2,817 +3%
Morgan Stanley
30
Morgan Stanley
New York
$2.46M +$149K +5,415 +6%
RA
31
Royce & Associates
New York
$2.26M – – –
Swiss National Bank
32
Swiss National Bank
Switzerland
$1.82M +$104K +3,800 +5%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.78M -$98.9K -3,600 -5%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.77M -$404K -14,715 -17%
AA
35
ALPS Advisors
Colorado
$1.76M +$346K +12,613 +21%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$1.71M +$1.51M +54,899 +354%
Millennium Management
37
Millennium Management
New York
$1.63M +$1.43M +52,086 +346%
Balyasny Asset Management
38
Balyasny Asset Management
Illinois
$1.58M -$647K -23,543 -27%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$1.56M -$36.9K -1,345 -2%
AllianceBernstein
40
AllianceBernstein
Tennessee
$1.45M -$43.9K -1,600 -3%
CS
41
Credit Suisse
Switzerland
$1.33M +$241K +8,757 +19%
DZ Bank
42
DZ Bank
Germany
$1.24M +$1.4M +51,134 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$1.12M – – –
HP
44
Hound Partners
New York
$1.02M +$1.16M +42,082 New
Renaissance Technologies
45
Renaissance Technologies
New York
$977K +$1.11M +40,300 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$922K -$17.3K -630 -2%
Bank of America
47
Bank of America
North Carolina
$872K +$63K +2,295 +7%
NSEDCP
48
NJ State Employees Deferred Compensation Plan
New Jersey
$828K – – –
VEA
49
Virtus ETF Advisers
New York
$800K -$53.3K -1,940 -6%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$752K – – –
1
2
3 4

TBPH Hedge Fund Activity: Q1 2018 in Review

90 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q1 2018, worth a combined $1.16B — down 12% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TBPH positions and 7 closed out — a net gain of 7 holders — while 33 added to existing stakes and 26 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $11M. The largest seller was First Manhattan, cutting an estimated $22.4M.

  • 90 institutional investors held Theravance Biopharma (TBPH) as of Q1 2018, up from 84 in Q4 2017.
  • Funds reported $1.16B of Theravance Biopharma stock for Q1 2018, down 12% quarter-over-quarter.
  • 14 funds opened new Theravance Biopharma positions in Q1 2018 and 7 closed out, a net change of +7 holders.
  • The largest Theravance Biopharma buyer in Q1 2018 was Cormorant Asset Management, an estimated $11M added.
  • The largest Theravance Biopharma seller in Q1 2018 was First Manhattan, an estimated $22.4M sold.

Based on aggregated 13F filings for Q1 2018.